[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337643-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337643-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cytidine-deaminase-resolves-replicative-stress-and-protects-pancreatic-cancer-from-dna-targeting-drugs-abstract","Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs - Abstract","","Cytidine deaminase (CDA) supports pyrimidine salvage for DNA and RNA synthesis and protects cancer cells from deoxycytidine-based chemotherapy. In pancreatic adenocarcinoma, CDA is overexpressed at baseline and is required for experimental tumor growth. CDA localizes to replication forks, increasing replication speed, improving fork restart, lowering replication stress, minimizing DNA breaks, and maintaining genetic stability. High CDA expression correlates with resistance to DNA-damaging agents, while CDA silencing elevates stress and sensitizes to oxaliplatin, suggesting CDA as a predictive marker and target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cytidine-deaminase-resolves-replicative-stress-and-protects-pancreatic-cancer-from-dna-targeting-drugs-abstract/337643/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cytidine-deaminase-resolves-replicative-stress-and-protects-pancreatic-cancer-from-dna-targeting-drugs-abstract/337643.png","ImageObject",300,407,{"name":42,"@type":43},"Ava Thompson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does cytidine deaminase (CDA) play in pancreatic adenocarcinoma?","Question",{"text":63,"@type":64},"CDA is overexpressed in pancreatic adenocarcinoma at baseline and is essential for experimental tumor growth. It also correlates with resistance to DNA-damaging agents.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does CDA influence DNA replication mechanics?",{"text":68,"@type":64},"CDA localizes to replication forks, increases replication speed, improves replication fork restart efficiency, reduces endogenous replication stress, minimizes DNA breaks, and regulates genetic stability during DNA replication.",{"name":70,"@type":61,"acceptedAnswer":71},"What happens when CDA is silenced in pancreatic cancer models?",{"text":72,"@type":64},"Silencing CDA in patient-derived primary cultures and in orthotopic xenografts increases replication stress and sensitizes pancreatic adenocarcinoma cells to oxaliplatin. This indicates CDA as a potential therapeutic vulnerability.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337643,1790142091,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs  \nAudrey Lumeau1, Nicolas Bery1, Audrey Francs1, Marion Gayral1, Guillaume Labrousse1, Cyril Ribeyre2, Charlene Lopez1, Adele Nevot1, AbdessamadEl Kaoutari3, NaimaHanoun1, EmelineSarot1, Marion Perrier1, Frederic Pont1, Juan-Pablo Cerapio1, Jean-Jacques Fourni1, Frederic Lopez1, Miguel Madrid-Mencia1, Vera Pancaldi1,4, Marie-Jeanne Pillaire5, Valerie Bergoglio6, Jerome Torrisani1, Nelson Dusetti3, Jean-Sebastien Hoffmann7, Louis Buscail1,8, Malik Lutzmann2, and Pierre Cordelier1  \nABSTRACT  \n◥  \nCytidine deaminase (CDA) functions in the pyrimidine salvage pathway for DNA and RNA syntheses and has been shown to protect cancer cells from deoxycytidine-based chemotherapies. In this study, we observed that CDA was overexpressed in pancreatic adenocarcinoma from patients at baseline and was essential for experimental tumor growth. Mechanistic investigations revealed that CDA localized to replication forks where it increased replication speed, improved replication fork restart efﬁciency, reduced endogenous replication stress, minimized DNA breaks, and regulated genetic stability during DNA replication. In cellular pancreatic cancer models, high CDA expression correlated with resistance to DNA-damaging agents. Silencing CDA in patientderived primary cultures in vitro and in orthotopic xenografts  \nin vivo increased replication stress and sensitized pancreatic adenocarcinoma cells to oxaliplatin. This study sheds light on the role of CDA in pancreatic adenocarcinoma, offering insights into how this tumor type modulates replication stress. These ﬁndings suggest that CDA expression could potentially predict therapeutic efﬁcacy and that targeting CDA induces intolerable levels of replication stress in cancer cells, particularly when combined with DNA-targeted therapies.  \nSigniﬁcance: Cytidine deaminase reduces replication stress and regulates DNA replication to confer resistance to DNA-damaging drugs in pancreatic cancer, unveiling a molecular vulnerability that could enhance treatment response.  \nIntroduction  \nPancreatic ductal adenocarcinoma (PDAC) will soon become the second cause of death by cancer worldwide (1) . Recent studies demonstrate that 10% to 15% of patients with PDAC show unstable genotypes with chromosomal structural variations characterized by the inactivation of DNA repair genes (BRCA1, BRCA2, PALB2, ATM, and RAD51; refs. 2, 3) . Such molecular defects can advocate for promising targeted therapies (4) as transcriptomic signatures of high replication stress predict response to ATR and WEE1 inhibitors in preclinical models (5) . More importantly, patients with germline  \n1Centre de Recherches en Cancrologie de Toulouse, CRCT, Universit de Toulouse, Inserm, CNRS, Toulouse, France. 2Institut de Gntique Humaine, CNRS, Universit de Montpellier, Montpellier, France. 3Centre de Recherche en Cancrologie de Marseille, CRCM, Inserm, CNRS, Institut Paoli-Calmettes, Universit Aix-Marseille, Marseille, France. 4Barcelona Supercomputing Center, Barcelona, Spain. 5Institut de Pharmacologie et de Biologie Structurale, IPBS, Toulouse, France. 6Centre de Biologie Intgr . 7Laboratoire d’ Excellence Toulouse Cancer (TOUCAN), Laboratoire de pathologie, Institut Universitaire du Cancer-Toulouse, Toulouse, France. 8Service de gastroentrologie et d’hpatologie, CHU Rangueil, Universite de Toulouse, Toulouse,􀀃  France.  \nCorresponding Author: Pierre Cordelier, U1037 Cancer Research Center of Toulouse, INSERM, 2, Avenue Hubert Curien, Toulouse, 31037, France. E-mail:  \n[pierre.cordelier@inserm.fr](pierre.cordelier@inserm.fr)[ ](pierre.cordelier@inserm.fr)[Cancer Res 2024](Cancer Res 2024);[84:1013](84:1013)–[28](28)  \ndoi: 10.1158/0008-5472 . CAN-22-3219  \nThis open access article is distributed under the Creative Commons AttributionNonCommercial-NoDerivatives 4 . 0 International (CC BY-NC-ND 4 . 0) license.  \n􀀁2024The Authors;Published by the ","cbCailWG2Z1KBOZO","https://ap.wps.com/l/cbCailWG2Z1KBOZO","pdf",14686252,16,"English","# Abstract\n## Mechanistic findings\n## Therapeutic implications","[{\"question\":\"What role does cytidine deaminase (CDA) play in pancreatic adenocarcinoma?\",\"answer\":\"CDA is overexpressed in pancreatic adenocarcinoma at baseline and is essential for experimental tumor growth. It also correlates with resistance to DNA-damaging agents.\"},{\"question\":\"How does CDA influence DNA replication mechanics?\",\"answer\":\"CDA localizes to replication forks, increases replication speed, improves replication fork restart efficiency, reduces endogenous replication stress, minimizes DNA breaks, and regulates genetic stability during DNA replication.\"},{\"question\":\"What happens when CDA is silenced in pancreatic cancer models?\",\"answer\":\"Silencing CDA in patient-derived primary cultures and in orthotopic xenografts increases replication stress and sensitizes pancreatic adenocarcinoma cells to oxaliplatin. This indicates CDA as a potential therapeutic vulnerability.\"}]","Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs - Abstract | PDF",1790019966,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40900d519f07cd6ece7d37b0deafe8d9.webp",983,1286,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01dd4d2dbcd232e366ce16fe1bd4d8b9.webp",982,1285,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76e5f94f4ee955de0834e02d457b8dfd.webp",981,1283,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/609c8e5b303a18c8db32aecadd383834.webp",980,1282]